NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 08 04:00PM ET
10.67
Dollar change
+0.55
Percentage change
5.43
%
IndexRUT P/E- EPS (ttm)-3.22 Insider Own17.09% Shs Outstand42.23M Perf Week-6.49%
Market Cap491.97M Forward P/E- EPS next Y-0.80 Insider Trans-0.15% Shs Float38.23M Perf Month10.46%
Income-126.87M PEG- EPS next Q-0.80 Inst Own80.45% Short Float13.23% Perf Quarter-2.56%
Sales90.40M P/S5.44 EPS this Y1.29% Inst Trans2.16% Short Ratio9.94 Perf Half Y-10.56%
Book/sh-0.21 P/B- EPS next Y72.58% ROA-54.68% Short Interest5.06M Perf Year-22.96%
Cash/sh5.16 P/C2.07 EPS next 5Y- ROE- 52W Range8.94 - 20.70 Perf YTD0.19%
Dividend Est.- P/FCF- EPS past 5Y10.39% ROI-110.73% 52W High-48.45% Beta0.66
Dividend TTM- Quick Ratio5.81 Sales past 5Y13165.79% Gross Margin90.18% 52W Low19.35% ATR (14)0.84
Dividend Ex-Date- Current Ratio6.01 EPS Y/Y TTM13.49% Oper. Margin-107.06% RSI (14)50.74 Volatility9.84% 8.25%
Employees235 Debt/Eq- Sales Y/Y TTM9.29% Profit Margin-140.35% Recom1.25 Target Price32.62
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q-10.84% Payout- Rel Volume1.19 Prev Close10.12
Sales Surprise-4.17% EPS Surprise-11.16% Sales Q/Q4.40% EarningsMay 12 BMO Avg Volume508.82K Price10.67
SMA202.19% SMA500.70% SMA200-10.75% Trades Volume603,182 Change5.43%
Date Action Analyst Rating Change Price Target Change
Apr-16-25Initiated Scotiabank Sector Outperform $23
Feb-19-25Resumed Ladenburg Thalmann Buy $31
Aug-22-24Initiated Guggenheim Buy $40
Feb-08-23Downgrade Jefferies Buy → Hold $35 → $10
Apr-27-22Initiated Berenberg Buy $20
Apr-16-20Reiterated H.C. Wainwright Buy $53 → $57
Apr-13-20Reiterated H.C. Wainwright Buy $75 → $53
Jan-09-20Initiated National Securities Neutral $37
May-30-19Initiated JP Morgan Neutral
May-29-19Initiated Goldman Neutral
May-07-25 10:32AM
10:22AM
08:57AM
May-01-25 04:00PM
Apr-29-25 05:16AM
04:00PM Loading…
Apr-27-25 04:00PM
01:00PM
12:30PM
Apr-26-25 06:30PM
10:00AM
Apr-14-25 08:00AM
Apr-12-25 10:02AM
Mar-12-25 03:00PM
Mar-10-25 09:10AM
08:00AM
08:00AM Loading…
Mar-07-25 08:00AM
Feb-27-25 08:00AM
Feb-25-25 12:30PM
Feb-24-25 04:00PM
Feb-21-25 10:53AM
Feb-20-25 08:00AM
Feb-14-25 02:30PM
Feb-12-25 08:00AM
Jan-30-25 08:00AM
Jan-22-25 08:00AM
Jan-15-25 08:00AM
Dec-06-24 08:00AM
Dec-05-24 03:30PM
03:15PM
Dec-02-24 05:44PM
08:00AM Loading…
08:00AM
Nov-28-24 11:49AM
Nov-26-24 08:00AM
Nov-07-24 02:16AM
Nov-06-24 09:15AM
08:00AM
Nov-05-24 08:00AM
Oct-30-24 08:00AM
Oct-28-24 08:00AM
Oct-16-24 04:47AM
Oct-15-24 04:30PM
Oct-09-24 06:18PM
08:00AM
Oct-03-24 04:12AM
Oct-02-24 08:00AM
Sep-23-24 05:50AM
03:58AM
Sep-16-24 08:00AM
Sep-05-24 08:00AM
Aug-29-24 08:00AM
Aug-14-24 08:00AM
Aug-13-24 09:15AM
08:00AM
Aug-05-24 08:00AM
Aug-02-24 09:55AM
Aug-01-24 10:01AM
Jul-17-24 09:55AM
Jun-27-24 01:54PM
Jun-17-24 10:51PM
04:46PM
05:00AM
Jun-13-24 04:05PM
10:45AM
Jun-07-24 08:00AM
Jun-06-24 08:00AM
Jun-05-24 08:00AM
Jun-03-24 08:00AM
May-22-24 08:00AM
May-14-24 08:20AM
May-13-24 12:53PM
09:32AM
08:00AM
May-07-24 08:00AM
May-05-24 12:20PM
May-04-24 03:20PM
11:50AM
May-03-24 08:00AM
Apr-17-24 12:02PM
Apr-15-24 08:00AM
Apr-03-24 08:00AM
Mar-15-24 10:30AM
Mar-14-24 12:53PM
09:32AM
09:10AM
08:00AM
Mar-08-24 08:00AM
Mar-04-24 08:00AM
Feb-26-24 08:00AM
Feb-01-24 08:00AM
Jan-24-24 08:00AM
Jan-17-24 08:00AM
Jan-11-24 08:00AM
Dec-08-23 04:00PM
Nov-15-23 01:50PM
Nov-14-23 12:19PM
08:00AM
Nov-13-23 08:00AM
Nov-07-23 08:00AM
Oct-03-23 08:00AM
Sep-11-23 07:00AM
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schoenberg MarkChief Medical OfficerJan 31 '25Sale11.144,55150,698145,666Feb 04 11:53 AM
Smith Jason DrewGeneral CounselJan 31 '25Sale11.147,37982,20226,468Feb 04 11:51 AM
Schoenberg MarkChief Medical OfficerSep 09 '24Sale13.0885911,236145,091Sep 12 01:54 PM
Smith Jason DrewGeneral CounselSep 09 '24Sale13.081,52119,89525,226Sep 12 01:51 PM
Schoenberg MarkOfficerSep 09 '24Proposed Sale13.2385911,365Sep 10 07:16 AM
Schoenberg MarkChief Medical OfficerJun 10 '24Sale13.085,15367,401144,284Jun 11 01:15 PM